Back to Search
DANIEL GLEASON, MD
MD
Pediatrics Physician
NPI: 1346230331Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
MD11923(OR)
Research & Publications (20)
Ependymal stem cells divide asymmetrically and transfer progeny into the subventricular zone when activated by injury.
PMID 18682279·Neuroscience·2008
7-preclinical
Climate change, coral reef ecosystems, and management options for marine protected areas.
PMID 19636605·Environ Manage·2009
7-preclinical
Transforming growth factor-alpha induces neurogenesis and behavioral improvement in a chronic stroke model.
PMID 19248822·Neuroscience·2009
7-preclinical
Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WWS outside of the Middle East.
PMID 18752264·Hum Mutat·2008
8-other
Disposable plastic rodent feeders for use in an automated filling system.
PMID 18719694·Lab Anim (NY)·2008
7-preclinical
Identifying autism loci and genes by tracing recent shared ancestry.
PMID 18621663·Science·2008
7-preclinical
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
PMID 18485407·J Urol·2008
3-trial
Latitudinal variation in spongivorous fishes and the effectiveness of sponge chemical defenses.
PMID 17960425·Oecologia·2008
4-observational
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases.
PMID 17956712·Clin Genitourin Cancer·2007
2-rct
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.
PMID 16753373·J Urol·2006
4-observational
Development of a coral cDNA array to examine gene expression profiles in Montastraea faveolata exposed to environmental stress.
PMID 16115654·Mar Pollut Bull·2005
4-observational
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
PMID 15173273·J Natl Cancer Inst·2004
3-trial
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.
PMID 15134983·Urology·2004
3-trial
Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases.
PMID 15110375·J Clin Anesth·2004
5-case
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
PMID 12771706·J Urol·2003
3-trial
Ionic reaction of halogens with terminal alkenes: the effect of electron-withdrawing fluorine substituents on the bonding of halonium ions.
PMID 12737574·J Org Chem·2003
8-other
A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer.
PMID 12501882·Clin Ther·2002
3-trial
The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.
PMID 12442349·Cancer Invest·2002
4-observational
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
PMID 12359855·J Natl Cancer Inst·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 19260 SW 65TH AVE, STE 340
TUALATIN, OR 97062 - Phone
- (503) 691-9777
Quick Facts
- NPI
- 1346230331
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile